Lexaria Receives Patent Protection in Japan
New patent granted in Japan adds to existing patents in the EU, the U.S., India and Australia
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces an additional expansion of its intellectual property portfolio with its first-ever patent granted in Japan.